Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus
- PMID: 25955648
- PMCID: PMC4463646
- DOI: 10.3390/ijms160510281
Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects approximately 1-45.3 per 100,000 people worldwide. Although deaths as a result of active and renal diseases have been substantially declining amongst SLE patients, disease involving the central nervous system (CNS), collectively termed neuropsychiatric systemic lupus erythematosus (NPSLE), remains one of the important causes of death in these patients. Cognitive dysfunction is one of the most common manifestations of NPSLE, which comprises deficits in information-processing speed, attention and executive function, in conjunction with preservation of speech. Albeit a prevalent manifestation of NPSLE, the pathogenetic mechanisms of cognitive dysfunction remain unclear. Recent advances in genetic studies, molecular techniques, neuropathology, neuroimaging and cognitive science have gleaned valuable insights into the pathophysiology of lupus-related cognitive dysfunction. In recent years, a role for autoantibodies, molecular and cellular mechanisms in cognitive dysfunction, has been emerging, challenging our previous concept of the brain as an immune privileged site. This review will focus on the potential pathogenic factors involved in NPSLE, including anti-N-methyl-d-aspartate receptor subunit NR2A/B (anti-NR2A/B) antibodies, matrix metalloproteinase-9, neutrophil extracellular traps and pro-inflammatory mediators. Better understanding of these mechanistic processes will enhance identification of new therapeutic modalities to halt the progression of cognitive decline in SLE patients.
Figures
Similar articles
-
Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.Front Immunol. 2022 Aug 9;13:957303. doi: 10.3389/fimmu.2022.957303. eCollection 2022. Front Immunol. 2022. PMID: 36016935 Free PMC article. Review.
-
Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.Int J Rheum Dis. 2019 Mar;22(3):443-448. doi: 10.1111/1756-185X.13392. Epub 2018 Oct 24. Int J Rheum Dis. 2019. PMID: 30358102
-
Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.Lupus. 2015 May;24(6):558-68. doi: 10.1177/0961203314555538. Epub 2014 Oct 15. Lupus. 2015. PMID: 25318968
-
[Central neuropsychiatric involvement in systemic lupus erythematosus].Rev Med Suisse. 2012 Apr 18;8(337):848-53. Rev Med Suisse. 2012. PMID: 22594009 French.
-
The role of B cells and autoantibodies in neuropsychiatric lupus.Autoimmun Rev. 2016 Sep;15(9):890-5. doi: 10.1016/j.autrev.2016.07.009. Epub 2016 Jul 5. Autoimmun Rev. 2016. PMID: 27389531 Free PMC article. Review.
Cited by
-
Headaches in SLE patients: a cross-sectional analysis of clinical, immunological, and Radiological Correlations.BMC Rheumatol. 2024 Oct 31;8(1):57. doi: 10.1186/s41927-024-00424-4. BMC Rheumatol. 2024. PMID: 39478616 Free PMC article.
-
The Intersection of Autoimmunity and Neurology: Insights From a Case of Striatal Lupus Encephalitis.Cureus. 2024 Sep 5;16(9):e68743. doi: 10.7759/cureus.68743. eCollection 2024 Sep. Cureus. 2024. PMID: 39371814 Free PMC article.
-
Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairment.Rheumatology (Oxford). 2023 Nov 2;62(11):3610-3618. doi: 10.1093/rheumatology/keac653. Rheumatology (Oxford). 2023. PMID: 36394258 Free PMC article.
-
Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.Front Immunol. 2022 Aug 9;13:957303. doi: 10.3389/fimmu.2022.957303. eCollection 2022. Front Immunol. 2022. PMID: 36016935 Free PMC article. Review.
-
Role of the Extracellular Traps in Central Nervous System.Front Immunol. 2021 Nov 16;12:783882. doi: 10.3389/fimmu.2021.783882. eCollection 2021. Front Immunol. 2021. PMID: 34868063 Free PMC article. Review.
References
-
- Fragoso-Loyo H., Richaud-Patin Y., Orozco-Narvaez A., Davila-Maldonado L., Atisha-Fregoso Y., Llorente L., Sanchez-Guerrero J. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum. 2007;56:1242–1450. doi: 10.1002/art.22451. - DOI - PubMed
-
- Faust T.W., Chang E.H., Kowal C., Berlin R., Gazaryan I.G., Bertini E., Zhang J., Sanchez-Guerrero J., Fragoso-Loyo H.E., Volpe B.T., et al. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc. Natl. Acad. Sci. USA. 2010;107:18569–18574. doi: 10.1073/pnas.1006980107. - DOI - PMC - PubMed
-
- Hanly J.G., Urowitz M.B., Sanchez-Guerrero J., Bae S.C., Gordon C., Wallace D.J., Isenberg D., Alarcon G.S., Clarke A., Bernatsky S., et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study. Arthritis Rheum. 2007;56:265–273. doi: 10.1002/art.22305. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical